Published June 7, 2023 | Version v1
Book chapter Open

In Silico Identification of Possible Mutation-Prone Regions of the GRIA3

Creators

  • 1. Yildiz Technical University

Description

This book section is published in Current Debates on Natural and Engineering Sciences 1th Edition Volume 9.

Files

Zeynep Nur KESKİN ICENSS - In Silico Identification of Possible Mutation-Prone Regions of the GRIA3 BOOK SECTION.pdf

Files (203.1 kB)

Additional details

References

  • Beneyto, M., Kristiansen, L., Oni-Orisan, A. et al. (2007). Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacol. 32,1888–1902 doi: 10.1038/sj.npp.1301312
  • Capriotti E, Calabrese R, Casadio R. (2006). Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics. 22, 2729-2734. doi: 10.1093/bioinformatics/btl423
  • Capriotti E, Fariselli P and Casadio R (2005). I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure.,Nucl. Acids Res. 33: W306-W310
  • Choudhury A, Mohammad T, et al., (2022 May). Comparative analysis of web-based programs for single amino acid substitutions in proteins. PLoS One. 17(5):e0267084. doi: 10.1371/journal.pone.0267084.
  • García-Gaytán AC, Hernández-Abrego A, Díaz-Muñoz M, Méndez I. (2022 Nov). Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs. Front Endocrinol (Lausanne). 13:1029210. doi: 10.3389/fendo.2022.1029210
  • Greger IH, Watson JF, Cull-Candy SG. (2017 May). Structural and functional architecture of AMPA-Type glutamate receptors and their auxiliary proteins. Neuron. 94(4):713-730. doi: 10.1016/j.neuron.2017.04.009
  • Guo C, Ma YY. (2021 Aug). Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders. Front Neural Circuits. 15:711564. doi: 10.3389/fncir.2021.711564
  • Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, Traynelis SF. (2018 Aug). Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol. 150(8):1081-1105. doi: 10.1085/jgp.201812032
  • Jablensky A. (2010). The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues Clin Neurosci. 12(3):271-87. doi: 10.31887/DCNS.2010.12.3/ajablensky
  • Kamalova A, Nakagawa T. (2021 Jan). AMPA receptor structure and auxiliary subunits. J Physiol. 599(2):453-469. doi: 10.1113/JP278701
  • Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. (2003 Nov). Protein disorder prediction: implications for structural proteomics. Structure. 11(11):1453-9. doi: 10.1016/j.str.2003.10.002
  • Malacards. (2023 May). GRIA3. Malacards: Human Disease Database. Date of Access: 21.05.2023, URL: https://www.malacards.org/search/results/GRIA3?startPage=0
  • Millan MJ, Andrieux A, et al., (2016 Jul). Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 15(7):485-515. doi: 10.1038/nrd.2016.28
  • Moghaddam B, Javitt D. (2012 Jan). From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 37(1):4-15. doi: 10.1038/npp.2011.181
  • NCBI-National Center for Biotechnology. (2023). Home Page. Date of Access: May 6, 2023, from https://www.ncbi.nlm.nih.gov/
  • Ng PC, Henikoff S. (2006). Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet. 7:61-80. doi: 10.1146/annurev.genom.7.080505.115630.
  • Ou L, Przybilla MJ, Whitley CB. (2017 Jul). Phenotype prediction for mucopolysaccharidosis type I by in silico analysis. Orphanet J Rare Dis. 12(1):125. doi: 10.1186/s13023-017-0678-1
  • Rizzato F, Rodriguez A, Biarnés X, Laio A. (2017 Oct) Predicting amino acid substitution probabilities using single nucleotide polymorphisms. Genetics. 207(2):643-652. doi: 10.1534/genetics.117.300078
  • Saldanha L, Langel Ü, Vale N. (2023 Feb). In silico studies to support vaccine development. Pharmaceutics. 15(2):654. doi: 10.3390/pharmaceutics15020654.
  • Singh T, et al. (2022 Apr). Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 604(7906):509-516. doi: 10.1038/s41586-022-04556-w
  • Smeland, O.B., Frei, O., Dale, A.M. et al. (2020). The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology. Nat Rev Neurol 16, 366–379. doi: 10.1038/s41582-020-0364-0
  • Soremekun OS, Ezenwa C, et al., (2021) Transcription-translation error: In-silico investigation of the structural and functional impact of deleterious single nucleotide polymorphisms in GULP1 gene. Inform Med Unlocked. 22:100503. doi: 10.1016/j.imu.2020.100503.
  • Stępnicki P, Kondej M, Kaczor AA.(2018 Aug). Current concepts and treatments of schizophrenia. Molecules. 23(8):2087. doi: 10.3390/molecules23082087
  • Uno Y, Coyle JT. (2019 May). Glutamate hypothesis in schizophrenia. Psychiatry Clin Neurosci. 73(5):204-215. doi: 10.1111/pcn.12823
  • 73(5):204-215. doi: 10.1111/pcn.12823 Yonezawa K, Tani H, et al., (2022 May). AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. Schizophr Res. 243:98-109. doi: 10.1016/j.schres.2022.02.033